Prisma Capital Partners’s Humana HUM Stock Holding History

Prisma Capital Partners’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-29,600	Closed	-$7.12M	–	11
2017 Q2	$7.12M	Buy	+29,600	New	+$6.7M	10.86%	2

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Prisma Capital Partners's HUM Position: Q3 2017 in Review

Prisma Capital Partners sold out of Humana (HUM) in Q3 2017, closing a stake of 29,600 shares — an estimated $7.12M sold.

Prisma Capital Partners first reported a position in HUM in Q2 2017 and held it in 1 quarter. The position peaked at $7.12M in Q2 2017. 655 funds tracked by Wall St. Rank hold HUM as of Q3 2017.

Prisma Capital Partners reported no remaining Humana position as of Q3 2017 after selling out during the quarter.
Prisma Capital Partners sold 29,600 Humana shares in Q3 2017, an estimated $7.12M.
Prisma Capital Partners first reported a position in Humana in Q2 2017 and held it in 1 quarter.
Prisma Capital Partners's Humana position peaked at $7.12M in Q2 2017.
655 funds tracked by Wall St. Rank held Humana as of Q3 2017.

Based on Prisma Capital Partners's 13F filing for Q3 2017, filed 14 Nov 2017.